Ye et al. found that down regulated lncRNA CLMAT3 promotes the proliferation of colorectal cancer cells by targeting regulators of the cell cycle pathway (path:04110)23, and low proteasome (path:03050) activity was related to treatment resistance in colorectal cancer24. This evidence concerns the gene CLMAT3 and colorectal cancer.